151 related articles for article (PubMed ID: 38156835)
1. E74-like Factor 5 Promoter Methylation in Circulating Tumor DNA as a Potential Prognostic Marker in Breast Cancer Patients.
Salimi M; Rastegarpouyani S
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4035-4041. PubMed ID: 38156835
[TBL] [Abstract][Full Text] [Related]
2. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer.
Mastoraki S; Balgkouranidou I; Tsaroucha E; Klinakis A; Georgoulias V; Lianidou E
Mol Oncol; 2021 Sep; 15(9):2412-2422. PubMed ID: 33159839
[TBL] [Abstract][Full Text] [Related]
3. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
4. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract][Full Text] [Related]
7. Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.
Skrypkina I; Tsyba L; Onyshchenko K; Morderer D; Kashparova O; Nikolaienko O; Panasenko G; Vozianov S; Romanenko A; Rynditch A
Dis Markers; 2016; 2016():3693096. PubMed ID: 27725787
[TBL] [Abstract][Full Text] [Related]
8. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.
Chimonidou M; Tzitzira A; Strati A; Sotiropoulou G; Sfikas C; Malamos N; Georgoulias V; Lianidou E
Clin Biochem; 2013 Feb; 46(3):235-40. PubMed ID: 23006792
[TBL] [Abstract][Full Text] [Related]
9. SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer.
Chimonidou M; Strati A; Malamos N; Georgoulias V; Lianidou ES
Clin Chem; 2013 Jan; 59(1):270-9. PubMed ID: 23136251
[TBL] [Abstract][Full Text] [Related]
10. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
11. Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.
Pakneshan P; Têtu B; Rabbani SA
Clin Cancer Res; 2004 May; 10(9):3035-41. PubMed ID: 15131040
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
13. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
14. Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer.
Rahvar F; Salimi M; Mozdarani H
Genet Mol Biol; 2020; 43(4):e20190230. PubMed ID: 33211060
[TBL] [Abstract][Full Text] [Related]
15. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.
Carraway HE; Wang S; Blackford A; Guo M; Powers P; Jeter S; Davidson NE; Argani P; Terrell K; Herman JG; Lange JR
Breast Cancer Res Treat; 2009 Mar; 114(2):315-25. PubMed ID: 18404369
[TBL] [Abstract][Full Text] [Related]
18. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
[TBL] [Abstract][Full Text] [Related]
19. Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients.
Li D; Li P; Wu J; Yi J; Dou Y; Guo X; Yin Y; Wang D; Ma C; Qiu L
Clin Chim Acta; 2018 Sep; 484():81-86. PubMed ID: 29775621
[TBL] [Abstract][Full Text] [Related]
20. Breast-Specific Molecular Clocks Comprised of
Miyano M; Sayaman RW; Shalabi SF; Senapati P; Lopez JC; Angarola BL; Hinz S; Zirbes A; Anczukow O; Yee LD; Sedrak MS; Stampfer MR; Seewaldt VL; LaBarge MA
Cancer Prev Res (Phila); 2021 Aug; 14(8):779-794. PubMed ID: 34140348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
